After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Get the (ATTBF) Report Here
Trade with Jim Cramer 14 Days FREE
GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.
Companies in the cannabis business have an appetite for capital to fuel what has emerged as one of the largest growth sectors, and more investors are taking the risk.
Abattis Bioceuticals Signs $25 Million Deal With Dutchess Fund
The Toronto-based wealth management and securities company helped aspiring pot grower Enertopia raise over a million dollars but, upon being informed by TheStreet that it had been credited in a regulatory filing, Canaccord wasn't feeling the vibes.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.